Object reference not set to an instance of an object. Online Stock Broker - Stock Broking, Best Share Bazaar Brokers In India
Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Budget News

  • Market at day's low, broader mkt rallies
  • December 02,2022  11:33
  • The key equity barometers declined further and hit a fresh intraday low in mid-morning trade. Negative global cues dented the investors sentiment. The Nifty traded below the 18,700 level. Media, PSU bank and realty stocks edged higher while auto, pharma and financial services stocks corrected.

    At 11:30 IST, the barometer index, the S&P BSE Sensex, was down 453.6 points or 0.72% to 62,830.59. The Nifty 50 index shed 133.10 points or 0.71% to 18,679.40.

    The broader market outperformed the headline indices. The S&P BSE Mid-Cap index rose 0.46% while the S&P BSE Small-Cap index added 0.45%.

    The market breadth was positive. On the BSE, 1,902 shares rose and 1,382 shares fell. A total of 154 shares were unchanged.

    IPO Update:

    The initial public offer (IPO) of Uniparts India received bids for 2,88,84,850 shares as against 1,01,37,360 shares on offer, according to stock exchange data at 11:21 IST on Friday (2 December 2022). The issue was subscribed 2.85 times.

    The issue opened for bidding on Wednesday (30 November 2022) and it will close on Friday (2 December 2022). The price band of the IPO is fixed at Rs 548-577 per share. An investor can bid for a minimum of 25 equity shares and in multiples thereof.

    Buzzing Index:

    The Nifty Metal index fell 0.69% to 13,029.60. The index shed 0.87% in two trading sessions.

    Divis Laboratories (down 1.76%), Cipla (down 1.72%), Abbott India (down 1%), Gland Pharma (down 0.97%), Biocon (down 0.95%), Sun Pharmaceuticals Industries (down 0.9%), Laurus Labs (down 0.43%), Torrent Pharmaceuticals (down 0.42%), Sanofi India (down 0.17%) and Lupin (down 0.13%) declined.

    On the other hand, Pfizer (up 1.55%) ,Natco Pharma (up 1.16%) and Zydus Lifesciences (up 0.51%) advanced.

    Stocks in Spotlight:

    Ashiana Housing rose 1.27% after the company entered into an agreement to develop a group housing project with approximate saleable area of 4.00 lakh sq. ft at Murlipura in Jaipur, Rajasthan.

    SJVN added 1.40% after the company's wholly owned subsidiary, SJVN Green Energy has signed a memorandum of understanding with Grid Corporation of Odisha for developing 1000 MW Hydro Electric Projects and 2000 MW Solar Power Projects in Odisha.

    MOIL rallied 4.24% after the company's production jumped 60% sequentially to 1.2 lakh tonne in November 2022. On the sales front, MOIL said that it has recorded a growth of 82% during the period over the previous month, in spite of challenging market conditions.

    Global Markets:

    Asian stocks tumbled on Friday as investors looked for clarity after China signaled slight easing of its stringent Covid restrictions.

    South Korea's consumer prices rose 5% in November from a year earlier, government data showed on Friday. The November inflation rate compared with 5.7% in October. The country's inflation rate has been falling since hitting a 24-year high of 6.3% in July as global energy prices eased and the economy slowed.

    US stocks ended mixed on Thursday as investors awaited jobs data coming Friday that could determine the pace of the Federal Reserve's future rate tightening.

    Powered by Capital Market - Live News

Economy News
Global News

Follow us:

  • fb icon
  • Twitter icon
  • Linkedin
  • you tube
  • Instagram

Disclaimer:

SMC Global Securities Ltd | CIN : L74899DL1994PLC063609 | Registered Office: 11/6B, Shanti Chamber, Pusa Road, Delhi-110005. | Tel +91-11-30111000 | Compliance Officer: Mr. Ashok Kumar Aggarwal | Tel 011-30111000 Extn. 170 | Email:-aka@smcindiaonline.com| Customer Care Email –smc.care@smcindiaonline.com| Complaint Email –igc@smcindiaonline.com| website: www.smctradeonline.com

SEBI Reg. No. INZ000199438, Member: NSE (07714), BSE (470), MSEI (1002), MCX (8200) & NCDEX (00021). DP SEBI Regn. No. CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH100001849, Mutual Funds Distributor ARN No. 29345. •Insurance services are offered through SMC Insurance Brokers Pvt. Ltd. IRDAI Regn. No: DB 272/04 License No. 289 Valid upto 27/01/2026. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. PMS is not offered in commodity derivative segment. Insurance is the subject matter of solicitation. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise.

By submitting your details to SMC, you are authorizing us to send promotional communication through Call/Email/SMS/Whatsapp even though you may be registered under DND.

OUR OTHER WEBSITES Go
IMPORTANT LINKS Go
QUICK LINKS
Go

Toll-free : 1800-11-0909
Email: contact@smctradeonline.com

Sitemap
Plus Minus 
Copyright ©2016-2024 SMC. All Rights Reserved | Disclaimer | Privacy Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)

Open my trading account now!  X 

* All fields are compulsory